Beyond diabetes mellitus: close pathological association of mutations of the KCNQ1 gene with other systemic disorders

Free article

Comment

Shailendra Kapoor. Ann Acad Med Singap. 2012 May.

Free article

. 2012 May;41(5):233.

No abstract available

Comment on

KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects.
Saif-Ali R, Muniandy S, Al-Hamodi Z, Lee CS, Ahmed KA, Al-Mekhlafi AM, Ismail IS. Saif-Ali R, et al. Ann Acad Med Singap. 2011 Nov;40(11):488-92. Ann Acad Med Singap. 2011. PMID: 22206064

Casting a wider net for diabetes susceptibility genes.
McCarthy MI. McCarthy MI. Nat Genet. 2008 Sep;40(9):1039-40. doi: 10.1038/ng0908-1039. Nat Genet. 2008. PMID: 19165915 No abstract available.
KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects.
Saif-Ali R, Muniandy S, Al-Hamodi Z, Lee CS, Ahmed KA, Al-Mekhlafi AM, Ismail IS. Saif-Ali R, et al. Ann Acad Med Singap. 2011 Nov;40(11):488-92. Ann Acad Med Singap. 2011. PMID: 22206064
Association of genetic variation in KCNQ1 with type 2 diabetes in the KORA surveys.
Grallert H, Herder C, Marzi C, Meisinger C, Wichmann HE, Rathmann W, Illig T. Grallert H, et al. Horm Metab Res. 2010 Feb;42(2):149-51. doi: 10.1055/s-0029-1241170. Epub 2009 Oct 1. Horm Metab Res. 2010. PMID: 19798621 Clinical Trial. No abstract available.
The KCNQ1 potassium channel: from gene to physiological function.
Jespersen T, Grunnet M, Olesen SP. Jespersen T, et al. Physiology (Bethesda). 2005 Dec;20:408-16. doi: 10.1152/physiol.00031.2005. Physiology (Bethesda). 2005. PMID: 16287990 Review.
Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers.
Tkáč I, Gotthardová I. Tkáč I, et al. Pharmacogenomics. 2016 May;17(7):795-804. doi: 10.2217/pgs-2016-0011. Epub 2016 May 11. Pharmacogenomics. 2016. PMID: 27166975 Review.